ATE404577T1 - Verfahren zur herstellung von eplerenon - Google Patents

Verfahren zur herstellung von eplerenon

Info

Publication number
ATE404577T1
ATE404577T1 AT03745535T AT03745535T ATE404577T1 AT E404577 T1 ATE404577 T1 AT E404577T1 AT 03745535 T AT03745535 T AT 03745535T AT 03745535 T AT03745535 T AT 03745535T AT E404577 T1 ATE404577 T1 AT E404577T1
Authority
AT
Austria
Prior art keywords
eplerenone
producing
producing eplerenone
7alpha
processes
Prior art date
Application number
AT03745535T
Other languages
English (en)
Inventor
Bruce Pearlman
Amphlett Padilla
Jeffrey Havens
Sonja Mackey
Haifeng Wu
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE404577T1 publication Critical patent/ATE404577T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03745535T 2002-03-22 2003-03-21 Verfahren zur herstellung von eplerenon ATE404577T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36678402P 2002-03-22 2002-03-22
US41187402P 2002-09-19 2002-09-19
US42559602P 2002-11-12 2002-11-12

Publications (1)

Publication Number Publication Date
ATE404577T1 true ATE404577T1 (de) 2008-08-15

Family

ID=28678917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03745535T ATE404577T1 (de) 2002-03-22 2003-03-21 Verfahren zur herstellung von eplerenon

Country Status (23)

Country Link
US (2) US20040024202A1 (de)
EP (2) EP1490390A2 (de)
JP (2) JP2005528371A (de)
KR (3) KR20050028907A (de)
CN (2) CN100473660C (de)
AT (1) ATE404577T1 (de)
AU (2) AU2003220251A1 (de)
BR (2) BR0308660A (de)
CA (2) CA2474072A1 (de)
CY (1) CY1108453T1 (de)
DE (1) DE60322852D1 (de)
DK (1) DK1487859T3 (de)
ES (1) ES2310666T3 (de)
HK (1) HK1078588A1 (de)
IL (2) IL164166A0 (de)
MX (2) MXPA04009216A (de)
MY (1) MY138479A (de)
PL (2) PL373189A1 (de)
PT (1) PT1487859E (de)
RS (2) RS83104A (de)
SI (1) SI1487859T1 (de)
TW (2) TW200401781A (de)
WO (2) WO2003082894A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CL2004000574A1 (es) * 2003-03-21 2005-02-11 Pharmacia Corp Sa Organizada B Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
CN1310941C (zh) * 2005-07-13 2007-04-18 南京大学 依普利酮的合成方法
CN1321128C (zh) * 2005-07-15 2007-06-13 浙江医药股份有限公司新昌制药厂 孕甾－4－烯－7，21－二甲酸，9，11－环氧－17－羟基－3－氧代，γ－内酯，甲酯，(7α,11α,17α)－的制备方法
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
JP2007297352A (ja) * 2006-05-02 2007-11-15 Toho Earthtech Inc ヨウ化アルキルの製造方法および２−アルキル置換シクロヘキサノンの製造方法
EP2171077B1 (de) * 2007-07-11 2012-11-28 DSM IP Assets B.V. Enantioselektive Reduktion
EP2265629B1 (de) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylen-17-carbolactone und damit in zusammenhang stehende anwendungen
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
CN102464551B (zh) * 2010-11-17 2014-03-26 中国石油化工股份有限公司 异丁烯歧化反应制四甲基乙烯的方法
ES2699923T3 (es) 2014-10-17 2019-02-13 Ind Chimica Srl Proceso para la preparación de 7alfa-(metoxicarbonil)-3-oxo-17alfa-pregn-4,9(11)-dien-21,17-carbolactona, un intermedio útil para la síntesis de moléculas con actividad farmacológica
CN105753930A (zh) * 2016-03-30 2016-07-13 北京万全德众医药生物技术有限公司 依普利酮的一种合成方法
CN108003156B (zh) * 2018-01-29 2021-04-20 辽宁科技大学 一种咪唑并吡啶基1,2-乙二酮衍生物的合成方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US464741A (en) * 1891-12-08 Seed-planter
US3053856A (en) * 1958-10-29 1962-09-11 Shell Oil Co Epoxidation of ethylenic compounds with peroxycarboximidic acids
US3200113A (en) * 1963-01-09 1965-08-10 Sterling Drug Inc 7-cyano steroids and derivatives thereof
US3300489A (en) * 1964-07-24 1967-01-24 Smith Kline French Lab Steroidal c-17 spirolactones and processes and intermediates used in the preparation thereof
US3413288A (en) * 1965-07-07 1968-11-26 Parke Davis & Co Process for the production of steroidal c-17 spirolactones
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
DE2404947C2 (de) * 1973-02-06 1983-04-21 Roussel-Uclaf, 75007 Paris Steroidspirolactone, Verfahren zu ihrer Herstellung und deren Verwendung
FR2216276B1 (de) * 1973-02-06 1976-11-05 Roussel Uclaf
FR2216273B1 (de) * 1973-02-06 1977-07-22 Roussel Uclaf
FR2260569B1 (de) * 1974-02-08 1978-06-16 Ugine Kuhlmann
US3957826A (en) * 1974-03-04 1976-05-18 Hoffmann-La Roche Inc. Spirolactone production
FR2281357A1 (fr) * 1974-08-08 1976-03-05 Roussel Uclaf Nouveau procede de preparation de spirolactones steroides
FR2285137A1 (fr) * 1974-09-18 1976-04-16 Roussel Uclaf Nouveaux derives steroides 17-spirosultines, les g-hydroxyacides correspondants, leur procede de preparation et leur application comme medicament
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
US4069219A (en) * 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
US4270994A (en) * 1980-02-20 1981-06-02 G. D. Searle & Co. Electrochemical dehydrogenation of steroidal Δ3,5 enol ethers under basic conditions to provide steroidal Δ4,6 dienones
DE3344057A1 (de) * 1982-12-09 1984-06-14 Ciba-Geigy Ag, Basel Eine neue lactonverbindung und pharmazeutische zusammensetzungen davon, sowie verfahren zu ihrer herstellung
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
PT85891B (pt) * 1986-10-10 1990-07-31 Roussel Uclaf Processo para a preparacao de 9-alfa-hidroxi-esteroides e dos respectivos derivados 9(11)-deidro bem como de composicoes farmaceuticas que os contem
FR2610933B1 (fr) * 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
AU680818B2 (en) * 1992-05-21 1997-08-14 Endorecherche Inc. Improved antiandrogens
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
ATE365171T1 (de) * 1995-12-11 2007-07-15 Searle Llc Verfahren zur herstellung einer epoxyverbindung
ATE375992T1 (de) * 1996-12-11 2007-11-15 Searle Llc Epoxidierungsverfahren
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone

Also Published As

Publication number Publication date
US20040024202A1 (en) 2004-02-05
CA2480151A1 (en) 2003-10-09
ES2310666T3 (es) 2009-01-16
CA2474072A1 (en) 2003-10-09
SI1487859T1 (sl) 2008-10-31
WO2003082895A2 (en) 2003-10-09
TW200404079A (en) 2004-03-16
IL164159A0 (en) 2005-12-18
EP1490390A2 (de) 2004-12-29
KR20050028907A (ko) 2005-03-23
IL164166A0 (en) 2005-12-18
RS90504A (en) 2006-10-27
BR0308660A (pt) 2005-01-25
PL372460A1 (en) 2005-07-25
EP1487859B1 (de) 2008-08-13
JP2005523306A (ja) 2005-08-04
US20070129332A1 (en) 2007-06-07
DK1487859T3 (da) 2008-10-06
MXPA04009216A (es) 2005-01-25
WO2003082894A2 (en) 2003-10-09
CN1633445A (zh) 2005-06-29
JP2005528371A (ja) 2005-09-22
CN1653081A (zh) 2005-08-10
AU2003220251A1 (en) 2003-10-13
MXPA04009178A (es) 2004-11-26
PL373189A1 (en) 2005-08-22
TW200401781A (en) 2004-02-01
BR0308466A (pt) 2005-04-26
PT1487859E (pt) 2008-10-23
TWI283245B (en) 2007-07-01
EP1487859A2 (de) 2004-12-22
HK1078588A1 (en) 2006-03-17
CY1108453T1 (el) 2014-04-09
WO2003082895A3 (en) 2004-04-22
AU2003259022A1 (en) 2003-10-13
DE60322852D1 (de) 2008-09-25
KR20040097201A (ko) 2004-11-17
MY138479A (en) 2009-06-30
KR20100131018A (ko) 2010-12-14
WO2003082894A3 (en) 2004-04-15
CN100473660C (zh) 2009-04-01
RS83104A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
HK1078588A1 (en) Process to prepare eplerenone
DE50303413D1 (de) Befestigungsmittel und Verfahren zu seiner Herstellung
ATE276235T1 (de) Verfahren zur herstellung von thiocarbonsäuren
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE50303749D1 (de) Verfahren zur herstellung von phthalocyaninpigmentzubereitungen
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE472251T1 (de) Verfahren zur fruchtausdünnung
ATE402684T1 (de) Elastische befestigungslasche, befestigungssystem und verfahren zur herstellung davon
ATE542810T1 (de) Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
ATE337796T1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
DE60308388D1 (de) 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
ATE446965T1 (de) Verfahren zur herstellung von fluticasone propionaten, insbesondere polymorph 1
ATE353872T1 (de) Katalytisches verfahren zur herstellung von perfluorethansulfonylfluorid und/oder perfluordiethylsulfon
DE50211253D1 (de) Verfahren zur Herstellung von Makrokapseln
DE60213217D1 (de) Verfahren zur Herstellung von lithographischen Masken
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
ATE341558T1 (de) Verfahren zur herstellung von topiramate
ATE453659T1 (de) Verfahren zur herstellung von 7-alpha- methylsteroide
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE325111T1 (de) Verfahren zur herstellung von 15-pentadecanolid
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE60332384D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487859

Country of ref document: EP